Imugene Limited (AU:IMU) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Imugene Limited announced the successful passing of all resolutions at its Annual General Meeting, despite facing a ‘first strike’ due to over 25% of votes opposing the 2024 Remuneration Report. The company remains committed to advancing its innovative immuno-oncology therapies and is well-positioned to achieve significant milestones in the global cancer treatment market.
For further insights into AU:IMU stock, check out TipRanks’ Stock Analysis page.
